Commercial
  
  
  
  
  
  
  
  
  
  
  
MPattachmentdataPub
  
ada343ed-55fd-47f1-a622-45a5121fce5b.aspx
  
Continuous Local Delivery of Anesthesia to Operative Sites Using an Elastomeric Infusion Pump01.00.09cAnesthesia (01)Continuous Local Delivery of Anesthesia to Operative Sites Using an Elastomeric Infusion Pumpada343ed-55fd-47f1-a622-45a5121fce5b3007Continuous Local Delivery of Anesthesia to Operative Sites Using an Elastomeric Infusion Pump01.00.092/26/2021 1:00 PM
cf267f32-6e0a-48a8-a141-cb0d525d6175.aspx
  
PercutaneousCoronaryIntervention,CoronaryAngiographyandArterialUltrasound(Independence)11.02.27d11.02.27dSurgery (11)Percutaneous Coronary Intervention, Coronary Angiography and Arterial Ultrasound (Independence)cf267f32-6e0a-48a8-a141-cb0d525d61752729Percutaneous Coronary Intervention, Coronary Angiography and Arterial Ultrasound (Independence)11.02.2712/14/2020 2:00 PM
{"2730": {"Id":2730,"MPAttachmentLetter":"A","Title":"Percutaneous Coronary Intervention, Coronary Angiography and Arterial Ultrasound Code List","MPPolicyAttachmentInternalSourceId":4948,"PolicyAttachmentPageName":"213d6cfa-6a4f-48a5-95c7-14a3a61ba6bb"},}
3/14/2021
1f2e0f11-325c-4e80-9ded-8a68a449e33e.aspx
  
High-TechnologyRadiologyServices(Independence)09.00.46af09.00.46afRadiology (09)High-Technology Radiology Services (Independence)1f2e0f11-325c-4e80-9ded-8a68a449e33e2734High-Technology Radiology Services (Independence)09.00.4612/14/2020 3:00 PM
{"2735": {"Id":2735,"MPAttachmentLetter":"A","Title":"High-Technology Radiology Services Code List","MPPolicyAttachmentInternalSourceId":4918,"PolicyAttachmentPageName":"82905e38-3e23-4912-9d77-1f9236351b31"},}
3/14/2021
e38d5005-93de-4610-99fc-79e774c6ebc9.aspx
  
KneeOrthoses05.00.47o05.00.47oDME (05)Knee Orthosese38d5005-93de-4610-99fc-79e774c6ebc92999Knee Orthoses05.00.472/12/2021 2:00 PM
3/15/2021
8872c12a-7e06-482b-894a-716f6f2c81a6.aspx
  
SubcutaneousImplantableCardioverterDefibrillator(S-ICD)forTreatingLife-threateningVentricularTachyarrhythmia05.00.77b05.00.77bDME (05)Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) for Treating Life-threatening Ventricular Tachyarrhythmia8872c12a-7e06-482b-894a-716f6f2c81a62789Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) for Treating Life-threatening Ventricular Tachyarrhythmia05.00.7712/22/2020 11:00 AM
3/22/2021
eecac08c-b51e-45f5-a752-dfa3912b5988.aspx
  
ModifiersforAssistant-at-SurgeryServices:80,81,82,andAS00.10.18n00.10.18nAdministrative (00)Modifiers for Assistant-at-Surgery Services: 80, 81, 82, and ASeecac08c-b51e-45f5-a752-dfa3912b59882989Modifiers for Assistant-at-Surgery Services: 80, 81, 82, and AS00.10.1812/29/2020 12:00 AM
3/29/2021
943def0a-9c65-4458-b3a9-1f7a97553db4.aspx
  
Filgrastim(Neupogen®)andrelatedbiosimilars,andtbo-filgrastim(Granix®)08.01.7308.01.73Pharmacy (08)Filgrastim (Neupogen ®) and related biosimilars, and tbo-filgrastim (Granix ®)943def0a-9c65-4458-b3a9-1f7a97553db42821Filgrastim  (Neupogen ®) and related biosimilars, and tbo-filgrastim (Granix ®)08.01.7312/31/2020 10:00 AM
{"2822": {"Id":2822,"MPAttachmentLetter":"A","Title":"EXAMPLES OF DISEASE SETTINGS AND CHEMOTHERAPY REGIMENS WITH A HIGH (>20%) OR INTERMEDIATE (10-20%) RISK FOR FEBRILE NEUTROPENIA","MPPolicyAttachmentInternalSourceId":5087,"PolicyAttachmentPageName":"4ef3a473-0336-444f-b8c4-ec80cfaaabae"},}
4/1/2021
3e82c09c-bc79-4c88-89b6-de4f430754c3.aspx
  
TelemedicineServices(Independence)00.10.41h00.10.41hAdministrative (00)Telemedicine Services (Independence)3e82c09c-bc79-4c88-89b6-de4f430754c32833Telemedicine Services (Independence)00.10.4112/31/2020 1:00 PM
4/1/2021
fffc063e-3d02-4e7c-9f1e-9e0c56aa022a.aspx
  
pegfilgrastim(Neulasta®)andrelatedbiosimilars08.01.32e08.01.32ePharmacy (08)pegfilgrastim (Neulasta®) and related biosimilarsfffc063e-3d02-4e7c-9f1e-9e0c56aa022a2857pegfilgrastim (Neulasta®) and related biosimilars08.01.3212/31/2020 2:00 PM
{"2858": {"Id":2858,"MPAttachmentLetter":"A","Title":"EXAMPLES OF DISEASE SETTINGS AND CHEMOTHERAPY REGIMENS WITH A HIGH (>20%) OR INTERMEDIATE (10-20%) RISK FOR FEBRILE NEUTROPENIA","MPPolicyAttachmentInternalSourceId":4771,"PolicyAttachmentPageName":"d5252565-c3d8-44fc-927c-20466d2f6dba"},}
4/1/2021